NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 231 participants.

Also called NCT02483143

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 231 participants (enrolled count) (from the registry)
Sponsor
Karadeniz Technical University (from the registry)
Registry
  • NCT NCT02483143
Other papers using this trial's data
  • The High Risk of Contrast-induced Nephropathy in Patients with Suspected Pulmonary Embolism Despite Three Different Prophylaxis: A Randomized Controlled Trial Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2016-10 DOI, PubMed 27411777

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Türkiye (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02483143. Randomized; triple masking; primary purpose prevention. Start 2014-02 (registry gives no type); primary completion 2015-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial
Condition
Radiographic Contrast Agent Nephropathy
Intervention (Drug)
NAC
Intervention (Drug)
NaHCO3
Intervention (Drug)
Normal Saline
Lead sponsor
Karadeniz Technical University (class: other)

Record details

Record id
cardio:ct-nct02483143
Content hash
ff731ee7486fac690ee223595389805cfb3edffac13ea4644d6218433a96e16e